Vaccination of calves with an attenuated cell line of Theileria annulata and the sporozoite antigen SPAG-1 produces a synergistic effect
- 1 November 2006
- journal article
- Published by Elsevier in Veterinary Parasitology
- Vol. 142 (1-2) , 54-62
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Evaluation of recombinant sporozoite antigen SPAG‐1 as a vaccine candidate against Theileria annulata by the use of different delivery systemsTropical Medicine & International Health, 1999
- Immunity and Vaccine Development in the Bovine TheileriosesAdvances in Parasitology, 1999
- Evidence for strain specificity in cytotoxic T-lymphocyte-mediated, major histocompatibility complex class I-dependent killing of Theileria annulata -infected cellsParasitology Research, 1998
- Different Vaccine Strategies Used to Protect against Theileria annulataaAnnals of the New York Academy of Sciences, 1998
- Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720Vaccine, 1997
- A preliminary study on the attenuation of Tunisian schizont-infected cell lines of Theileria annulataParasitology Research, 1996
- Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trialVaccine, 1995
- Theileria annulata sporozoite surface antigen (SPAG‐1) contains neutralizing determinants in the C terminusParasite Immunology, 1994
- Cell-mediated immune responses to sporozoites and macroschizonts of Theileria annulataVeterinary Parasitology, 1992
- Theileriasis : a comprehensive reviewScientific and Technical Review, 1989